Studying and treating Immunoglobulin A (IgA) Nephropathy for better patient outcomes

IgA neuropathy is a rare autoimmune disease that affects the peripheral nerves, most commonly in the legs and feet. Here’s a breakdown of the key components:

  • Autoimmune: In autoimmune diseases, the body’s immune system mistakenly attacks healthy tissues.
  • IgA: This refers to immunoglobulin A, a type of antibody normally produced by the immune system to fight infections. In IGA neuropathy, however, these antibodies become deposited in the small blood vessels supplying nerves, causing inflammation and damage.
  • Neuropathy: This refers to nerve damage, which can lead to symptoms like numbness, tingling, weakness, and pain in the affected areas.

Our IGA Neuropathy program focuses on research and treatment options for this condition. We are dedicated to advancing the understanding of IGA Neuropathy and developing new therapies to improve outcomes for patients.

Our team of experts is committed to conducting cutting-edge research that leads to new treatments and therapies for kidney health. Join us in our mission to make a difference in the lives of those affected by kidney disease.

Participate in our research trial for IGA Neuropathy and contribute to the advancement of knowledge and treatments for this condition. Register your interest here.